IL17A and chronic obstructive pulmonary disease: An experimental model of COPD involving mice exposed to cigarette smoke revealed that an oral gavage of Akk resulted in decreased lung tissue injury and inflammatory infiltration, with lower levels of IL-17, IL-6 and TNF-a in peripheral blood as well as improvements in autophagic markers [57].